17-3-1　ⓔ文献

  1. Hillman RS, Finch CA: Erythropoiesis; normal and abnormal. Semin Hematol, 1967; 4: 327–336.

  2. Tavian M, Biasch K, et al: Embryonic origin of human hematopoiesis. Int Dev Biol, 2010; 54: 1061–1065.

  3. Kantz SB, Jacobson LO: Erythropoietin and the regulation of erythropoiesis, University of Chicago Press, 1970.

  4. Greer SN, Metcalf JL, et al: The updated biology of hypoxia–inducible factor. EMBO J, 2013; 31: 2448–2460.

  5. Jaakkola P, Mole DR, et al: Targeting of HIF–alpha to the von–Hippel–Lindau ubiquitination complex by O2–regulated prolyl hydroxylation. Science, 2001; 292: 468–472.

  6. Aapro M, Gascon P, et al: Erythropoiesis–stimulating agents in the management of anemia in chronic kidney disease or cancer: A historical Perspective. Front Pharmacol, 2019; eCollection 2018.

  7. Maxwell PH, Eckardt K: HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond. Nat Rev Nephrol, 2016; 12: 157–168.

  8. Witthuhof BA, Quelle FW, et al: JAK2 associates with the erythropoietin receptor and its tyrosine phospholylated and activated following stimulation with erythropoietin. Cell, 1993; 74: 227–236.

  9. Penta K, Sawyer ST: Erythropoietin induces the tyrosine phospholylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid differentiation. J Biol Chem, 1995; 270: 31282–31287.

  10. Zhang J, Lodish HF: Endogenous K–ras signaling in erythroid differentiation. Cell Cycle, 2007; 6: 1970–1973.

  11. Skalak R, Branemark PI: Deformation of red blood cells in capillaries. Science, 1969; 164: 717–719.

  12. Hanspral M, Pale J: Biogenesis of normal and abnormal red blood cell membrane skeleton. Semin Hematol, 1992; 29: 301–319.

  13. Delaunary J: The molecular basis of hereditary red cell membrane disorders. Blood Rev, 2007; 21: 1–20.

  14. Schuster R, Holzhutter HG, et al: Interrelations between glycolysis and the hexose monophosphate shunt in erythrocytes as studied on the basis of mathematical model. Bio Syst, 1988; 22: 19–36.

  15. Mansouri A: Methemoglobin reduction under near physiological conditions. Biochem Med metab Biol, 1989; 42: 43–51.

  16. Heinemann IU, Jahn M, et al: The biochemistry of heme biosynthesis. Arch Biochem Biophys, 2008; 474: 238–251.

  17. Cao A, Moi P: Regulation of globin genes. Pediatr Res, 2002; 51: 415–421.

  18. Bunn HF, Jandl JF: Control of hemoglobin function within the red cell. New Engl J Med, 1970; 282: 1414–1421.

  19. Tanner MJ: Molecular and cellular biology of the erythrocyte anion exchanger AEI). Seminar Hematol, 1993; 30: 34–57.

  20. Gollan JL, Schmlid R: Bilirubin update: formation, transport, and metabolism. Prog Liver Dis, 1982; 7: 261–283.

  21. Green R, Chariton R, et al: Body iron excretion in man: a collaborative study. Am J Med, 1968; 45: 336–353.

  22. Theil E: Iron, ferritin, and nutrition. Ann Rev Nutr, 2004; 24: 327–343.

  23. Finch C: Regulators of iron balance in humans. Blood, 1994; 84: 3612–3613.

  24. Ganz T, Nemeth E: Hepcidin and disorders of iron metabolism. Annu Rev Med, 2011; 62: 347–360.

  25. Haile DJ, Rouault TA, et al: Reciprocal control of RNA–binding and aconitase activity in the regulation of iron–responsive element binding protein: role of iron–sulfur cluster. Proc Natl Acad Sci USA, 1992; 89: 7536–7540.

  26. Gunshin H, Mackenzie B, et al: Cloning and characterization of a mammalian proton–coupled metal–iron transporter. Nature, 1997; 388: 482–488.

  27. Aisen P: Transferrin receptor 1. Int J Biochem Cell Biol, 2004; 36: 2137–2143.

  28. Kohgo Y, Niitsu Y, et al: Serum transferrin receptor as a new index of erythropoiesis. Blood, 1987; 70: 1955–1958.

  29. Bratosin D, Mazurier J, et al: Cellular and molecular mechanisms of senescent erythrocyte–phagocytosis by macrophages. A review. Biochimie, 1998; 80: 173–195.

  30. Thomas C, Thomas L: Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol, 2005; 11: 14–23.

  31. Kawabata H, Yang R, et al: Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor–like family J Biol Chem, 1999; 274: 20826–20832.

  32. Enns CA, Ahmed R, et al: Increased iron loading induces BMP–6 in the non–parenchymal cells of the liver independent of the BMP–signaling pathway. PLos One, 2013; 8: e60534.

  33. Pietangelo A: Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology, 2010; 139: 393–408.

  34. Jacobs A, Worwood M: Ferritin in serum–Clinical and biochemical Implications. N Eng J Med, 1975; 292: 951–956.